Literature DB >> 20872013

Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.

Daichi Maeda1, Satoshi Ota, Yutaka Takazawa, Kenichi Ohashi, Masaya Mori, Tetsuo Imamura, Shunsuke Nakagawa, Tetsu Yano, Yuji Taketani, Masashi Fukayama.   

Abstract

Previous studies in Western countries have revealed that mucosal carcinoma of the fallopian tube frequently coexists with pelvic (ovarian, tubal, and peritoneal) serous carcinomas, and early tubal carcinoma is now regarded as a possible origin of these tumors. However, the relationship between early tubal carcinoma and non-serous ovarian cancer, such as clear cell adenocarcinoma, has not been studied in detail. In this study, we sought to examine the coexistence of mucosal carcinoma of the fallopian tube in Japanese ovarian cancer cases. We submitted the fallopian tubes in toto for histological examination in 52 ovarian carcinoma cases and three peritoneal serous carcinoma cases. The ovarian tumors included 12 serous adenocarcinomas, 23 clear cell adenocarcinomas, nine endometrioid adenocarcinomas, three mucinous adenocarcinomas, and four mixed epithelial carcinomas. Mucosal carcinoma of the fallopian tube did not coexist with non-serous adenocarcinoma (n = 40). In contrast, mucosal carcinoma of the fallopian tube was observed in six cases of ovarian serous adenocarcinoma and one case of peritoneal serous adenocarcinoma. In these cases, the p53 immunophenotypes were similar in tubal lesions and invasive ovarian or peritoneal carcinomas. Tumors were negative for p53 in four of seven cases, and one of the p53-negative serous adenocarcinomas showed low-grade morphology. We believe that some ovarian and peritoneal serous adenocarcinomas develop from early tubal carcinomas. However, it should be noted that early tubal carcinomas are not always p53-positive immunohistochemically. Finally, it is unlikely that early tubal lesions are involved in the carcinogenesis of clear cell adenocarcinoma and other non-serous adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872013     DOI: 10.1007/s00428-010-0979-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

Review 1.  Specific keynote: hereditary ovarian cancer: what we know.

Authors:  Jeff Boyd
Journal:  Gynecol Oncol       Date:  2003-01       Impact factor: 5.482

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.

Authors:  Martin Köbel; Steve E Kalloger; Jon Carrick; David Huntsman; Haider Asad; Esther Oliva; Carol A Ewanowich; Robert A Soslow; C Blake Gilks
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

Review 4.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

5.  Ovarian and extraovarian endometriosis-associated cancer.

Authors:  Susan C Modesitt; Guillermo Tortolero-Luna; Jubilee B Robinson; David M Gershenson; Judith K Wolf
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

6.  Bilateral microscopic adenocarcinoma of the fallopian tubes detected by an endometrial cytologic smear.

Authors:  Daichi Maeda; Yutaka Takazawa; Satoshi Ota; Yuko Takeuchi; Akira Seta; Shunsuke Nakagawa; Tetsu Yano; Yuji Taketani; Masashi Fukayama
Journal:  Int J Gynecol Pathol       Date:  2010-05       Impact factor: 2.762

Review 7.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

8.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

Review 9.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

10.  Histopathologic features of genetically determined ovarian cancer.

Authors:  P A Shaw; J R McLaughlin; R P Zweemer; S A Narod; H Risch; R H M Verheijen; A Ryan; F H Menko; P Kenemans; I J Jacobs
Journal:  Int J Gynecol Pathol       Date:  2002-10       Impact factor: 2.762

View more
  8 in total

1.  Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.

Authors:  Kala Visvanathan; Russell Vang; Patricia Shaw; Amy Gross; Robert Soslow; Vinita Parkash; Ie-Ming Shih; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

2.  Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.

Authors:  Russell Vang; Kala Visvanathan; Amy Gross; Emily Maambo; Mamta Gupta; Elisabetta Kuhn; Rose Fanghong Li; Brigitte M Ronnett; Jeffrey D Seidman; Anna Yemelyanova; Ie-Ming Shih; Patricia A Shaw; Robert A Soslow; Robert J Kurman
Journal:  Int J Gynecol Pathol       Date:  2012-05       Impact factor: 2.762

3.  Primary peritoneal serous carcinoma with signet ring cells.

Authors:  Yanru Hou; Yi Li; Danhua Shen; Heng Cui
Journal:  Gynecol Oncol Case Rep       Date:  2011-10-11

4.  Evaluation of SEE-FIM (Sectioning and Extensively Examining the FIMbriated End) Protocol in Identifying Fallopian Tube Precursor Lesions in Women with Ovarian Tumors.

Authors:  Swati Arora; B R Yelikar; Mahesh H Karigoudar
Journal:  J Obstet Gynaecol India       Date:  2018-07-25

Review 5.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

6.  Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.

Authors:  Satoru Munakata; Toshiya Yamamoto
Journal:  Int J Gynecol Pathol       Date:  2015-01       Impact factor: 2.762

Review 7.  Pathogenesis and heterogeneity of ovarian cancer.

Authors:  Paul T Kroeger; Ronny Drapkin
Journal:  Curr Opin Obstet Gynecol       Date:  2017-02       Impact factor: 1.927

8.  Fallopian Tube Epithelial Changes in Ovarian Serous Tumors Compared with Control Group: A Single-Center Study.

Authors:  Fatemeh Sari Aslani; Mona Maleknasab; Mojgan Akbarzadeh-Jahromi
Journal:  Niger Med J       Date:  2019 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.